Clinical Trial Update: To Evaluate the Safety and Efficacy for GORE TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated the safety and efficacy of the GORE TAG Thoracic Endoprosthesis for thoracic aortic disease; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Dissection
• Thoracic Aortic Aneurysm

Drugs mentioned

• GORE TAG Thoracic Endoprosthesis

Snippet

Sponsor: Stanford University | Conditions: Aneurysm, Dissecting, Aortic Aneurysm, Thoracic | Phase 3 | Status: COMPLETED | Results posted: 2017-03-01